Medicare Advantage: Eight critical considerations for every organization as ESRD eligibility expands in 2021
16 January 2020
Medicare-eligible individuals with end-stage renal disease (ESRD) will be allowed to actively enroll in Medicare Advantage (MA) plans as of January 1, 2021. This paper provides a brief overview of the upcoming ESRD MA eligibility change and key questions each Medicare Advantage organization should consider when planning for 2021.
Explore more tags from this article
About the Author(s)
Katherine N. Kroening
Gokce Yilmaz
Contact us
We’re here to help you break through complex challenges and achieve next-level success.
Medicare Advantage: Eight critical considerations for every organization as ESRD eligibility expands in 2021
This paper provides a brief overview of the upcoming end-stage renal disease Medicare Advantage eligibility change and key questions each Medicare Advantage organization should consider when planning for 2021.
Kelly Backes, Katherine Kroening, Douglas Rodrigues , Gokce Yilmaz